An experimental treatment , percutaneous hepatic perfusion ( PHP ) , utilizes partial venovenous cardiopulmonary bypass to allow administration of high-dose chemotherapy directly and solely to the liver with filtration of chemotherapeutic agents from the blood prior to its return to the systemic circulation , thereby minimizing toxic systemic effects .